COMPASS Pathways plc
- CMPS
- NASDAQ
- Biotechnology
- Psilocybin Therapy (COMP360)
- Psychedelic Therapeutics
$10.75
Today −7.49%Quote Oct 16, 2026, 08:00 PM UTC
−28.33%over the last month
Max drawdown −29.2%From 1-month high −29.2%3 months −7.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.49B
Quote Oct 16
Next earnings
Nov 3
Expected, not confirmed
Analyst target
$18.63
+73.3% from here
Floor
$10.44
2.9% below price
Where the price sits
15 analysts
Analyst range, low to high
$13.00$25.00
- Price $10.75
- Resistance $10.79
- Consensus $18.63
The price is right under resistance. Analysts' average target sits about 73% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CMPSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
156